Annual Long Term Debt
$1.87 M
+$1.85 M+9126.60%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual long term debt is $1.87 million, with the most recent change of +$1.85 million (+9126.60%) on December 31, 2022.
- During the last 3 years, NAVB annual long term debt has risen by +$1.36 million (+265.61%).
- NAVB annual long term debt is now -96.92% below its all-time high of $60.75 million, reached on December 31, 2015.
Performance
NAVB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$300.00
-$200.00-40.00%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly long term debt is $300.00, with the most recent change of -$200.00 (-40.00%) on September 30, 2023.
- Over the past year, NAVB quarterly long term debt has dropped by -$200.00 (-40.00%).
- NAVB quarterly long term debt is now -100.00% below its all-time high of $60.95 million, reached on September 30, 2015.
Performance
NAVB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
NAVB Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9126.6% | -40.0% |
3 y3 years | +265.6% | -40.0% |
5 y5 years | +218.5% | -40.0% |
NAVB Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +9126.6% | -100.0% | at low |
5 y | 5-year | at high | +9126.6% | -100.0% | at low |
alltime | all time | -96.9% | >+9999.0% | -100.0% | at low |
Navidea Biopharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $300.00(-40.0%) |
Jun 2023 | - | $500.00(-100.0%) |
Mar 2023 | - | $1.96 M(+4.9%) |
Dec 2022 | $1.87 M(+9126.6%) | $1.87 M(+4.5%) |
Sep 2022 | - | $1.79 M(+148.2%) |
Jun 2022 | - | $722.40 K(+6292.9%) |
Mar 2022 | - | $11.30 K(-44.3%) |
Dec 2021 | $20.30 K(-93.1%) | $20.30 K(-30.0%) |
Sep 2021 | - | $29.00 K(-75.9%) |
Jun 2021 | - | $120.50 K(-42.5%) |
Mar 2021 | - | $209.40 K(-29.3%) |
Dec 2020 | $296.00 K(-42.2%) | $296.00 K(-22.1%) |
Sep 2020 | - | $380.20 K(-12.5%) |
Jun 2020 | - | $434.30 K(-15.5%) |
Mar 2020 | - | $513.70 K(+0.3%) |
Dec 2019 | $512.30 K(+9.3%) | $512.30 K(-10.9%) |
Sep 2019 | - | $575.10 K(-6.3%) |
Jun 2019 | - | $613.80 K(-10.5%) |
Mar 2019 | - | $686.00 K(+46.4%) |
Dec 2018 | $468.50 K(-20.3%) | $468.50 K(-3.9%) |
Sep 2018 | - | $487.50 K(+1.6%) |
Jun 2018 | - | $479.60 K(-16.2%) |
Mar 2018 | - | $572.60 K(-2.6%) |
Dec 2017 | $588.10 K(-93.9%) | $588.10 K(-93.9%) |
Dec 2016 | $9.64 M(-84.1%) | $9.64 M(-8.6%) |
Sep 2016 | - | $10.55 M(+10.8%) |
Jun 2016 | - | $9.52 M(-10.8%) |
Mar 2016 | - | $10.67 M(-82.4%) |
Dec 2015 | $60.75 M(+106.0%) | $60.75 M(-0.3%) |
Sep 2015 | - | $60.95 M(+3.6%) |
Jun 2015 | - | $58.84 M(+100.8%) |
Mar 2015 | - | $29.31 M(-0.6%) |
Dec 2014 | $29.48 M(+25.1%) | $29.48 M(-0.9%) |
Sep 2014 | - | $29.76 M(-2.2%) |
Jun 2014 | - | $30.44 M(-1.6%) |
Mar 2014 | - | $30.94 M(+31.3%) |
Dec 2013 | $23.57 M(+240.1%) | $23.57 M(-9.6%) |
Sep 2013 | - | $26.09 M(-4.2%) |
Jun 2013 | - | $27.23 M(+165.9%) |
Mar 2013 | - | $10.24 M(+47.8%) |
Dec 2012 | $6.93 M(+7.3%) | $6.93 M(+92.8%) |
Sep 2012 | - | $3.59 M(-15.1%) |
Jun 2012 | - | $4.23 M(-12.7%) |
Mar 2012 | - | $4.85 M(-24.9%) |
Dec 2011 | $6.46 M(-41.0%) | $6.46 M(>+9900.0%) |
Sep 2010 | - | $12.20 K(-9.0%) |
Jun 2010 | - | $13.40 K(-99.9%) |
Mar 2010 | - | $10.97 M(+0.2%) |
Dec 2009 | $10.95 M(+84.5%) | $10.95 M(+0.0%) |
Sep 2009 | - | $10.95 M(+77.0%) |
Jun 2009 | - | $6.18 M(+2.6%) |
Mar 2009 | - | $6.03 M(+1.6%) |
Dec 2008 | $5.93 M | $5.93 M(+2.8%) |
Sep 2008 | - | $5.77 M(+2.7%) |
Jun 2008 | - | $5.62 M(+3.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2008 | - | $5.41 M(+1.9%) |
Dec 2007 | $5.31 M(+8.8%) | $5.31 M(+151.2%) |
Sep 2007 | - | $2.11 M(-39.4%) |
Jun 2007 | - | $3.48 M(+2.9%) |
Mar 2007 | - | $3.39 M(-30.6%) |
Dec 2006 | $4.88 M(-18.8%) | $4.88 M(-24.0%) |
Sep 2006 | - | $6.42 M(+2.3%) |
Jun 2006 | - | $6.28 M(+2.3%) |
Mar 2006 | - | $6.14 M(+2.2%) |
Dec 2005 | $6.01 M(+8.8%) | $6.01 M(+2.2%) |
Sep 2005 | - | $5.88 M(+2.1%) |
Jun 2005 | - | $5.76 M(+2.0%) |
Mar 2005 | - | $5.65 M(+2.3%) |
Dec 2004 | $5.52 M(+1053.3%) | $5.52 M(>+9900.0%) |
Sep 2004 | - | $33.90 K(-9.4%) |
Jun 2004 | - | $37.40 K(-69.2%) |
Mar 2004 | - | $121.60 K(-74.6%) |
Dec 2003 | $478.80 K(+8934.0%) | $478.80 K(>+9900.0%) |
Mar 2003 | - | $1400.00(-73.6%) |
Dec 2002 | $5300.00(-73.5%) | $5300.00(-42.4%) |
Sep 2002 | - | $9200.00(-28.7%) |
Jun 2002 | - | $12.90 K(-21.8%) |
Mar 2002 | - | $16.50 K(-17.5%) |
Dec 2001 | $20.00 K(-39.2%) | $20.00 K(-14.5%) |
Sep 2001 | - | $23.40 K(-12.4%) |
Jun 2001 | - | $26.70 K(-10.7%) |
Mar 2001 | - | $29.90 K(-9.1%) |
Dec 2000 | $32.90 K(-97.5%) | $32.90 K(-8.4%) |
Sep 2000 | - | $35.90 K(-55.4%) |
Jun 2000 | - | $80.50 K(+45.6%) |
Mar 2000 | - | $55.30 K(-44.7%) |
Dec 1999 | $1.31 M(+743.6%) | - |
Jun 1999 | - | $100.00 K(0.0%) |
Mar 1999 | - | $100.00 K(-35.8%) |
Dec 1998 | $155.80 K(-92.5%) | $155.80 K(-96.7%) |
Sep 1998 | - | $4.70 M(+2.2%) |
Jun 1998 | - | $4.60 M(+4.5%) |
Mar 1998 | - | $4.40 M(+112.7%) |
Dec 1997 | $2.07 M(+106.9%) | $2.07 M(+3.4%) |
Sep 1997 | - | $2.00 M(+5.3%) |
Jun 1997 | - | $1.90 M(+46.2%) |
Mar 1997 | - | $1.30 M(+30.0%) |
Dec 1996 | $1.00 M(-9.1%) | $1.00 M(0.0%) |
Sep 1996 | - | $1.00 M(+66.7%) |
Jun 1996 | - | $600.00 K(0.0%) |
Mar 1996 | - | $600.00 K(-45.5%) |
Dec 1995 | $1.10 M(-8.3%) | $1.10 M(-8.3%) |
Sep 1995 | - | $1.20 M(+500.0%) |
Jun 1995 | - | $200.00 K(0.0%) |
Mar 1995 | - | $200.00 K(-83.3%) |
Dec 1994 | $1.20 M(+1100.0%) | $1.20 M(+200.0%) |
Sep 1994 | - | $400.00 K(0.0%) |
Jun 1994 | - | $400.00 K(+100.0%) |
Mar 1994 | - | $200.00 K(+100.0%) |
Dec 1993 | $100.00 K | $100.00 K(0.0%) |
Sep 1993 | - | $100.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual long term debt year-on-year change?
- What is Navidea Biopharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly long term debt year-on-year change?
What is Navidea Biopharmaceuticals annual long term debt?
The current annual long term debt of NAVB is $1.87 M
What is the all time high annual long term debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual long term debt is $60.75 M
What is Navidea Biopharmaceuticals annual long term debt year-on-year change?
Over the past year, NAVB annual long term debt has changed by +$1.85 M (+9126.60%)
What is Navidea Biopharmaceuticals quarterly long term debt?
The current quarterly long term debt of NAVB is $300.00
What is the all time high quarterly long term debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly long term debt is $60.95 M
What is Navidea Biopharmaceuticals quarterly long term debt year-on-year change?
Over the past year, NAVB quarterly long term debt has changed by -$200.00 (-40.00%)